RRC ID 43972
著者 Sugatani J, Uchida T, Kurosawa M, Yamaguchi M, Yamazaki Y, Ikari A, Miwa M.
タイトル Regulation of pregnane X receptor (PXR) function and UGT1A1 gene expression by posttranslational modification of PXR protein.
ジャーナル Drug Metab Dispos
Abstract Human UDP-glucuronosyltransferase (UGT) 1A1 is a critical enzyme responsible for detoxification and metabolism of endogenous and exogenous lipophilic compounds such as bilirubin. The present study shows how cyclin-dependent kinase (CDK) inhibitor roscovitine stimulated the expression of UGT1A1 in HepG2 cells. Pregnane X receptor (PXR)-mediated transactivation of UGT1A1 reporter gene was more prominently enhanced by roscovitine, compared with the basal-, constitutive androstane receptor (CAR)-, and aryl hydrocarbon receptor-mediated activities. We determined the regulatory mechanism of UGT1A1 expression through PXR's stimulation by roscovitine. Although phosphomimetic mutations at Thr290 and Thr408 retained the PXR protein in cytoplasm and attenuated the induction of UGT1A1 expression by both roscovitine and rifampicin, a mutation at Ser350 specifically reduced the activity of PXR induced by roscovitine. Immunoprecipitation analysis revealed that the T290D but not T408D mutant protein remained in cytoplasm by forming a complex with heat shock protein 90 and cytoplasmic CAR retention protein, whereas treatment with proteasome inhibitor MG-132 accumulated the T408D mutant protein in cytoplasm. Transfection with anti-CDK2 small interfering RNA (siRNA) but not anti-CDK1 or CDK5 siRNA led to enhanced expression of UGT1A1. S350D yellow fluorescent protein-PXR fusion protein could translocate from cytoplasm to nucleus similar to the wild-type protein but was detected as an acetylated protein, whose binding with retinoid X receptor (RXR) and histone deacetylase was impaired. Cotransfection with coactivator steroid receptor coactivator (SRC) 2 but not SRC-1 partly recovered its PXR activity. These results indicate that roscovitine stimulated the expression of UGT1A1 by inhibiting CDK2, which phosphorylated PXR at Ser350 to suppress binding with RXR and coactivator and maintain the acetylation of PXR protein.
巻・号 40(10)
ページ 2031-40
公開日 2012-10-1
DOI 10.1124/dmd.112.046748
PII dmd.112.046748
PMID 22829544
MeSH Acetylation Basic Helix-Loop-Helix Transcription Factors / metabolism Constitutive Androstane Receptor Cyclin-Dependent Kinase 2 / antagonists & inhibitors Cyclin-Dependent Kinase 2 / metabolism Dose-Response Relationship, Drug Down-Regulation Gene Expression Regulation, Enzymologic Glucuronosyltransferase / genetics Glucuronosyltransferase / metabolism* HSP40 Heat-Shock Proteins / metabolism HSP90 Heat-Shock Proteins / metabolism Heat-Shock Proteins Hep G2 Cells Humans Immunoprecipitation Molecular Chaperones Mutation Nuclear Receptor Coactivator 2 / metabolism Phosphorylation Pregnane X Receptor Protein Kinase Inhibitors / pharmacology Protein Processing, Post-Translational* / drug effects Protein Transport Purines / pharmacology RNA Interference Receptors, Aryl Hydrocarbon / metabolism Receptors, Cytoplasmic and Nuclear / metabolism Receptors, Steroid / drug effects Receptors, Steroid / genetics Receptors, Steroid / metabolism* Retinoid X Receptors / metabolism Rifampin / pharmacology Roscovitine Serine Time Factors Transcriptional Activation Transfection
IF 3.231
引用数 28
WOS 分野 PHARMACOLOGY & PHARMACY
リソース情報
ヒト・動物細胞 Hep G2